Search Results 91-100 of 19706 for Receptor

  1. Biotinylated Vectors as Ligand Screening Platforms - Virology, Vector and Vaccine Engineering: Michael A. Barry - Mayo Clinic Research

    Biotinylated protein ligands targeting toll-like receptors and scavenger receptors ... receptor, biotinylated asialofetuin targeting the dendritic asialofetuin ...

  2. Mayo researchers identify potential new treatment for subset of women with triple-negative breast cancer

    They determined that when estradiol binds with estrogen receptor beta in triple-negative breast cancer, it stimulates the expression of a group of proteins ...

  3. Mayo Clinic Minute: What is CAR-T cell therapy?

    Survival rates for aggressive lymphomas have improved significantly thanks to advances in treatment, such as chimeric antigen receptor-T cell therapy (CAR-T ...

  4. Radiology - Clinical trials

    ... receptor positive, estrogen receptor-positive, human epidermal growth receptor-2 negative metastatic breast cancer after progression on previous endocrine ...

  5. Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists - Mayo Clinic

    Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists · Overview · Participation eligibility · Participating Mayo ...

  6. A Regulator of Stem Cells - Mayo Clinic News Network

    The thrombin receptor PAR1 is a newly identified fundamental regulator of stem cell biology. “I like to think of this receptor like a switch,” says Dr.

  7. Researchers identify factors that impact central nervous system injury and repair - Mayo Clinic

    Role of protease-activated receptor 1 (PAR1) thrombin receptor. The studies have revealed that PAR1 helps regulate neurite growth via a mechanism involving a ...

  8. Mayo Clinic Identifies a Key Cellular Pathway in Prostate Cancer

    Central to development of nearly all prostate cancer cases are malfunctions in the androgen receptor — the cellular component that binds to male hormones.

  9. Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer - Mayo Clinic

    It is not yet known whether letrozole is more effective than a placebo in treating patients with hormone receptor-positive breast cancer. PURPOSE: This ...

  10. A Study to Evaluate the Safety and Effectiveness of Capivasertib + Fulvestrant Versus Placebo + Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Breast Cancer - Mayo Clinic

    ... Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Breast Cancer. Print details. Share; Facebook · Twitter. Overview ...